Bexarotene Patent Expiration

Bexarotene is Used for treating cutaneous lesions in patients with refractory or persistent stage IA and IB cutaneous T-cell lymphoma. It was first introduced by Valeant Pharmaceuticals Luxembourg Sarl in its drug Targretin on Dec 29, 1999. 10 different companies have introduced drugs containing Bexarotene.


Bexarotene Patents

Given below is the list of patents protecting Bexarotene, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Targretin US5962731 Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors Oct 05, 2016

(Expired)

Bausch
Targretin US5962731 Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors Oct 05, 2016

(Expired)

Valeant Luxembourg
Targretin US5780676 Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors Jul 14, 2015

(Expired)

Bausch
Targretin US5780676 Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors Jul 14, 2015

(Expired)

Valeant Luxembourg



Bexarotene's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Bexarotene Generic API Manufacturers

Several generic applications have been filed for Bexarotene. The first generic version for Bexarotene was by Bionpharma Inc and was approved on Aug 12, 2014. And the latest generic version is by Ascent Pharmaceuticals Inc and was approved on Sep 6, 2024.

Given below is the list of companies who have filed for Bexarotene generic, along with the locations of their manufacturing plants worldwide.


1. AMNEAL

Amneal Pharmaceuticals Llc has filed for 1 generic for Bexarotene. Given below are the details of the strengths of this generic introduced by Amneal.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1%

gel Prescription TOPICAL AB Apr 27, 2022


Manufacturing Plant Locations
New

Amneal's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Amneal as present at those locations.

Country City Firm Name
United States
East Hanover Amneal Pharmaceuticals LLC
Paterson Amneal Pharmaceuticals, Llc
Branchburg Amneal Pharmaceuticals, LLC
Glasgow Amneal Pharmaceuticals LLC
Brookhaven Amneal Pharmaceuticals of New York, LLC
Bridgewater Amneal Complex Products Research LLC
Piscataway Amneal Pharmaceuticals, LLC
Hauppauge Amneal Pharmaceuticals of New York, LLC
India
Hyderabad Amneal Oncology Private Limited
Tal Bavla, Ahmedabad Amneal Pharmaceuticals Pvt. Ltd.
Ahmedabad Amneal Pharmaceuticals Private Ltd.
Matoda Amneal Pharmaceuticals Private Ltd.





2. AMNEAL PHARMS NY

Amneal Pharmaceuticals Of Ny Llc has filed for 1 generic for Bexarotene. Given below are the details of the strengths of this generic introduced by Amneal Pharms Ny.

Strength Dosage Form Availability Application Pathway TE code Launch Date
75MG

capsule Prescription ORAL AB Sep 4, 2018





3. ANI PHARMS

Ani Pharmaceuticals Inc has filed for 1 generic for Bexarotene. Given below are the details of the strengths of this generic introduced by Ani Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
75MG

capsule Prescription ORAL AB May 8, 2018





4. ASCENT PHARMS INC

Ascent Pharmaceuticals Inc has filed for 1 generic for Bexarotene. Given below are the details of the strengths of this generic introduced by Ascent Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
75MG

capsule Prescription ORAL AB Sep 6, 2024





5. BIONPHARMA

Bionpharma Inc has filed for 1 generic for Bexarotene. Given below are the details of the strengths of this generic introduced by Bionpharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
75MG

capsule Prescription ORAL AB Aug 12, 2014


Manufacturing Plant Locations
New

Bionpharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Bionpharma as present at those locations.

Country City Firm Name
United States
Princeton Bionpharma Inc.





6. HIKMA

Hikma Pharmaceuticals Usa Inc has filed for 1 generic for Bexarotene. Given below are the details of the strengths of this generic introduced by Hikma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
75MG

capsule Prescription ORAL AB Jun 16, 2020


Manufacturing Plant Locations
New

Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.

Country City Firm Name
United States
Dayton Hikma Injectables USA Inc
Cherry Hill Hikma Pharmaceuticals USA Inc.
Carlsbad Hikma Cali Inc. DBA Leucadia Pharmaceuticals
Eatontown Hikma Pharmaceuticals USA, Inc.
Portugal
Terrugem Snt Hikma Farmaceutica, (Portugal) S.A.
Jordan
Amman Hikma Pharmaceuticals LLC





7. TEVA PHARMS USA

Teva Pharmaceuticals Usa has filed for 1 generic for Bexarotene. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
75MG

capsule Prescription ORAL AB Jan 14, 2021





8. UPSHER SMITH LABS

Upsher Smith Laboratories Llc has filed for 1 generic for Bexarotene. Given below are the details of the strengths of this generic introduced by Upsher Smith Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
75MG

capsule Prescription ORAL AB Jul 25, 2018